Overview
BMAP-27, or bovine myeloid antimicrobial peptide-27, is a member of the cathelicidin family known for its potent bactericidal properties. This peptide is especially effective against harmful bacteria, including Staphylococcus aureusStreptococcus uberisand Escherichia coli. As part of the innate immune system, BMAP-27 plays a crucial role in defending against infections while exhibiting amphipathic characteristics that enhance its antimicrobial efficacy.
Key Features
- Rapid bactericidal activity against various bacteria.
- Cationic and amphipathic properties facilitate interaction with microbial membranes.
- Supports research in immunology and infectious diseases.
- Potential applications in developing new antimicrobial therapies.
- Available for purchase, ensuring easy access for your research needs.
Specifications
| Product Name | BMAP-27 |
| Category | Peptides |
| Target Bacteria | Staphylococcus aureus, Streptococcus uberis, Escherichia coli |
| Cytotoxicity | Higher concentrations affect human erythrocytes and neutrophils |
FAQ
What is BMAP-27 used for?
BMAP-27 is primarily used in research to study its antimicrobial properties and potential applications in treating bacterial infections.
How does BMAP-27 work?
This peptide disrupts bacterial membranes due to its amphipathic nature, leading to rapid cell death of targeted bacteria.
Can BMAP-27 affect human cells?
While BMAP-27 is cytotoxic to human erythrocytes and neutrophils, this occurs at concentrations higher than those used for microbial activity.
Explore the potential of BMAP-27 and consider adding it to your lab’s peptide inventory. For additional options, check out our range of peptidesincluding Autocamtide-2 and CREBtide.




Reviews
There are no reviews yet.